drugset / Trial / NCT00464971

Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension Trial

NCT00464971

Phase 3 Completed 102 enrolled Novo Nordisk A/S
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This trial was conducted in the United States of America (USA). This trial aimed to evaluate safety and efficacy of 17-beta Estradiol in the treatment of atrophic vaginitis.

Timeline

Start
1995-01-31
Primary completion
1996-11-30
Completion
1996-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 25 ug Other